GU07-124

A Phase II Study of Neoadjuvant Dasatinib plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial GU07-124 being conducted in.
No data was found